{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:18:08Z","timestamp":1740122288349,"version":"3.37.3"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Changbai Mountain Scholars Program of The Peoples Government of Jilin Province","award":["2013046"],"award-info":[{"award-number":["2013046"]}]},{"name":"the Jilin Science and Technology Development Program","award":["20160101204JC"],"award-info":[{"award-number":["20160101204JC"]}]},{"name":"the Jilin Talent Development Foundation","award":["111860000"],"award-info":[{"award-number":["111860000"]}]},{"DOI":"10.13039\/501100004806","name":"Fok Ying Tong Education Foundation","doi-asserted-by":"publisher","award":["151022"],"award-info":[{"award-number":["151022"]}],"id":[{"id":"10.13039\/501100004806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China Grant","doi-asserted-by":"crossref","award":["31500957"],"award-info":[{"award-number":["31500957"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s10741-016-9582-3","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T09:57:01Z","timestamp":1473760621000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Recent advances of adapter proteins in the regulation of heart diseases"],"prefix":"10.1007","volume":"22","author":[{"given":"Li","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linna","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuntian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,13]]},"reference":[{"issue":"8","key":"9582_CR1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","volume":"123","author":"PA Heidenreich","year":"2011","unstructured":"Heidenreich PA et al (2011) Forecasting the future of cardiovascular disease in the United States a policy statement from the American Heart Association. Circulation 123(8):933\u2013944","journal-title":"Circulation"},{"issue":"6","key":"9582_CR2","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1074\/jbc.M310405200","volume":"279","author":"JR McMullen","year":"2004","unstructured":"McMullen JR et al (2004) The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110\u03b1) pathway. J Biol Chem 279(6):4782\u20134793","journal-title":"J Biol Chem"},{"issue":"5","key":"9582_CR3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.yjmcc.2012.02.001","volume":"52","author":"H Bugger","year":"2012","unstructured":"Bugger H et al (2012) Genetic loss of insulin receptors worsens cardiac efficiency in diabetes. J Mol Cell Cardiol 52(5):1019\u20131026","journal-title":"J Mol Cell Cardiol"},{"issue":"11","key":"9582_CR4","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.2337\/db13-0095","volume":"62","author":"Y Qi","year":"2013","unstructured":"Qi Y et al (2013) Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38\u03b1 MAPK during insulin resistance. Diabetes 62(11):3887\u20133900","journal-title":"Diabetes"},{"issue":"3","key":"9582_CR5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1440-1681.2007.04873.x","volume":"35","author":"JR McMullen","year":"2008","unstructured":"McMullen JR (2008) Role of insulin-like growth factor 1 and phosphoinositide 3-kinase in a setting of heart disease. Clin Exp Pharmacol Physiol 35(3):349\u2013354","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"8","key":"9582_CR6","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI119730","volume":"100","author":"Q Li","year":"1997","unstructured":"Li Q et al (1997) Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Investig 100(8):1991\u20131999","journal-title":"J Clin Investig"},{"issue":"2","key":"9582_CR7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1073\/pnas.0606663104","volume":"104","author":"JR McMullen","year":"2007","unstructured":"McMullen JR et al (2007) Protective effects of exercise and phosphoinositide 3-kinase(p110\u03b1) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 104(2):612\u2013617","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"9582_CR8","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1128\/MCB.00426-14","volume":"34","author":"C Riehle","year":"2014","unstructured":"Riehle C et al (2014) Insulin receptor substrates are essential for the bioenergetic and hypertrophic response of the heart to exercise training. Mol Cell Biol 34(18):3450\u20133460","journal-title":"Mol Cell Biol"},{"issue":"1","key":"9582_CR9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1474-9726.2011.00766.x","volume":"11","author":"M Vinciguerra","year":"2012","unstructured":"Vinciguerra M et al (2012) mIGF-1\/JNK1\/SirT1 signaling confers protection against oxidative stress in the heart. Aging Cell 11(1):139\u2013149","journal-title":"Aging Cell"},{"issue":"5","key":"9582_CR10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrcardio.2011.38","volume":"8","author":"F Arslan","year":"2011","unstructured":"Arslan F, de Kleijn DP, Pasterkamp G (2011) Innate immune signaling in cardiac ischemia. Nat Rev Cardiol 8(5):292\u2013300","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"9582_CR11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.pcad.2009.11.006","volume":"52","author":"LA Blauwet","year":"2010","unstructured":"Blauwet LA, Cooper LT (2010) Myocarditis. Prog Cardiovasc Dis 52(4):274\u2013288","journal-title":"Prog Cardiovasc Dis"},{"issue":"49","key":"9582_CR12","doi-asserted-by":"crossref","first-page":"19725","DOI":"10.1073\/pnas.1108586108","volume":"108","author":"E Mezzaroma","year":"2011","unstructured":"Mezzaroma E et al (2011) The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci USA 108(49):19725\u201319730","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"9582_CR13","doi-asserted-by":"crossref","first-page":"e2234","DOI":"10.1038\/cddis.2016.140","volume":"7","author":"Y Yang","year":"2016","unstructured":"Yang Y et al (2016) The emerging role of toll-like receptor 4 in myocardial inflammation. Cell Death Dis 7(5):e2234","journal-title":"Cell Death Dis"},{"issue":"7","key":"9582_CR14","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1089\/ars.2010.3728","volume":"15","author":"O Avlas","year":"2010","unstructured":"Avlas O et al (2010) Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility. Antioxid Redox Signal 15(7):1895\u20131909","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"9582_CR15","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.yjmcc.2010.02.020","volume":"48","author":"R Fallach","year":"2010","unstructured":"Fallach R et al (2010) Cardiomyocyte toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia. J Mol Cell Cardiol 48(6):1236\u20131244","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"9582_CR16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI0214942","volume":"109","author":"A Leo","year":"2002","unstructured":"Leo A et al (2002) Adapters in lymphocyte signaling. J Clin Invest 109(3):301\u2013309","journal-title":"J Clin Invest"},{"issue":"5346","key":"9582_CR17","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1126\/science.278.5346.2075","volume":"278","author":"T Pawson","year":"1997","unstructured":"Pawson T, Scott JD (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science 278(5346):2075\u20132080","journal-title":"Science"},{"issue":"44","key":"9582_CR18","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1038\/sj.onc.1204788","volume":"20","author":"JR Bradley","year":"2001","unstructured":"Bradley JR, Pober JS (2001) Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20(44):6482\u20136491","journal-title":"Oncogene"},{"issue":"6","key":"9582_CR19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","volume":"7","author":"A Yoshimura","year":"2007","unstructured":"Yoshimura A, Naka T, Kubo M (2007) SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7(6):454\u2013465","journal-title":"Nat Rev Immunol"},{"key":"9582_CR20","doi-asserted-by":"publisher","unstructured":"Chen Z (2016) Adapter proteins regulate insulin resistance and lipid metabolism in obesity. Sci Bull. doi: 10.1007\/s11434-016-1058-2","DOI":"10.1007\/s11434-016-1058-2"},{"issue":"25","key":"9582_CR21","doi-asserted-by":"crossref","first-page":"20773","DOI":"10.18632\/oncotarget.4770","volume":"6","author":"L Tao","year":"2015","unstructured":"Tao L et al (2015) Exercise for the heart: signaling pathways. Oncotarget 6(25):20773\u201320784","journal-title":"Oncotarget"},{"key":"9582_CR22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.302095","author":"SC Kolwicz","year":"2013","unstructured":"Kolwicz SC, Purohit S, Tian R (2013) Cardiac metabolism and its interactions with contraction, growth, and survival of the cardiomyocte. Circ Res. doi: 10.1161\/CIRCRESAHA.113.302095","journal-title":"Circ Res"},{"issue":"5","key":"9582_CR23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00395-009-0018-2","volume":"104","author":"R Dikow","year":"2009","unstructured":"Dikow R et al (2009) Effect of insulin and glucose infusion on myocardial infarction size in uraemic rats. Basic Res Cardiol 104(5):571\u2013579","journal-title":"Basic Res Cardiol"},{"issue":"6865","key":"9582_CR24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","volume":"414","author":"AR Saltiel","year":"2001","unstructured":"Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414(6865):799\u2013806","journal-title":"Nature"},{"issue":"3","key":"9582_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s13238-014-0030-7","volume":"5","author":"Y Du","year":"2014","unstructured":"Du Y, Wei T (2014) Inputs and outputs of insulin receptor. Protein Cell 5(3):203\u2013213","journal-title":"Protein Cell"},{"issue":"44","key":"9582_CR26","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1038\/sj.onc.1204776","volume":"20","author":"KS Ravichandran","year":"2001","unstructured":"Ravichandran KS (2001) Signaling via Shc family adapter proteins. Oncogene 20(44):6322\u20136330","journal-title":"Oncogene"},{"issue":"29","key":"9582_CR27","doi-asserted-by":"crossref","first-page":"20197","DOI":"10.1074\/jbc.M601859200","volume":"281","author":"M Obreztchikova","year":"2006","unstructured":"Obreztchikova M et al (2006) Distinct signaling functions for Shc isoforms in the heart. J Biol Chem 281(29):20197\u201320204","journal-title":"J Biol Chem"},{"issue":"3","key":"9582_CR28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/hh1501.094115","volume":"89","author":"D Cesselli","year":"2001","unstructured":"Cesselli D et al (2001) Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 89(3):279\u2013286","journal-title":"Circ Res"},{"issue":"2","key":"9582_CR29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cell.2005.05.011","volume":"122","author":"M Giorgio","year":"2005","unstructured":"Giorgio M et al (2005) Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122(2):221\u2013233","journal-title":"Cell"},{"issue":"8","key":"9582_CR30","doi-asserted-by":"crossref","first-page":"514","DOI":"10.18632\/aging.100182","volume":"2","author":"G Pani","year":"2010","unstructured":"Pani G (2010) P66SHC and ageing: ROS and TOR? Aging (Albany NY) 2(8):514\u2013518","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"9582_CR31","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1073\/pnas.0609656104","volume":"104","author":"GG Camici","year":"2007","unstructured":"Camici GG et al (2007) Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc Natl Acad Sci USA 104(12):5217\u20135222","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"9582_CR32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.HYP.0000174986.73346.ba","volume":"46","author":"G Graiani","year":"2005","unstructured":"Graiani G et al (2005) Genetic deletion of the p66Shc adaptor protein protects from angiotensin II\u2014induced myocardial damage. Hypertension 46(2):433\u2013440","journal-title":"Hypertension"},{"issue":"1","key":"9582_CR33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.biocel.2012.07.004","volume":"45","author":"CV Diogo","year":"2013","unstructured":"Diogo CV et al (2013) Cardiac mitochondrial dysfunction during hyperglycemia\u2014the role of oxidative stress and p66Shc signaling. Int J Biochem Cell Biol 45(1):114\u2013122","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"9582_CR34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00395-009-0008-4","volume":"104","author":"F Lisa Di","year":"2009","unstructured":"Di Lisa F et al (2009) Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66Shc and monoamine oxidase. Basic Res Cardiol 104(2):131\u2013139","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"9582_CR35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00395-015-0470-0","volume":"110","author":"A Baysa","year":"2015","unstructured":"Baysa A et al (2015) The p66ShcA adaptor protein regulates healing after myocardial infarction. Basic Res Cardiol 110(2):13","journal-title":"Basic Res Cardiol"},{"issue":"8","key":"9582_CR36","doi-asserted-by":"crossref","first-page":"516-U79","DOI":"10.1093\/eurheartj\/ehu400","volume":"36","author":"A Akhmedov","year":"2015","unstructured":"Akhmedov A et al (2015) Genetic deletion of the adaptor protein p66(Shc) increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways. Eur Heart J 36(8):516-U79","journal-title":"Eur Heart J"},{"issue":"32","key":"9582_CR37","doi-asserted-by":"crossref","first-page":"23285","DOI":"10.1074\/jbc.M600987200","volume":"281","author":"M Dance","year":"2006","unstructured":"Dance M et al (2006) The adaptor protein Gab1 couples the stimulation of vascular endothelial growth factor receptor-2 to the activation of phosphoinositide 3-kinase. J Biol Chem 281(32):23285\u201323295","journal-title":"J Biol Chem"},{"issue":"4","key":"9582_CR38","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1128\/MCB.24.4.1531-1539.2004","volume":"24","author":"Y Sun","year":"2004","unstructured":"Sun Y et al (2004) Role of Gab1 in UV-induced c-Jun NH2-terminal kinase activation and cell apoptosis. Mol Cell Biol 24(4):1531\u20131539","journal-title":"Mol Cell Biol"},{"issue":"13","key":"9582_CR39","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/MCB.23.13.4471-4484.2003","volume":"23","author":"M Holgado-Madruga","year":"2003","unstructured":"Holgado-Madruga M, Wong AJ (2003) Gab1 is an integrator of cell death versus cell survival signals in oxidative stress. Mol Cell Biol 23(13):4471\u20134484","journal-title":"Mol Cell Biol"},{"issue":"10","key":"9582_CR40","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1128\/MCB.20.10.3695-3704.2000","volume":"20","author":"M Itoh","year":"2000","unstructured":"Itoh M et al (2000) Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation. Mol Cell Biol 20(10):3695\u20133704","journal-title":"Mol Cell Biol"},{"issue":"6","key":"9582_CR41","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1083\/jcb.150.6.1375","volume":"150","author":"M Sachs","year":"2000","unstructured":"Sachs M et al (2000) Essential role of Gab1 for signaling by the c-Met receptor in vivo. J Cell Biol 150(6):1375\u20131384","journal-title":"J Cell Biol"},{"issue":"7","key":"9582_CR42","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1172\/JCI30651","volume":"117","author":"T Nakaoka","year":"2007","unstructured":"Nakaoka Y et al (2007) Gab family proteins are essential for postnatal maintenance of cardiac function via neuregulin-1\/ErbB signaling. J Clin Investig 117(7):1771\u20131781","journal-title":"J Clin Investig"},{"issue":"4","key":"9582_CR43","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/cdd.2015.143","volume":"23","author":"J Zhao","year":"2016","unstructured":"Zhao J et al (2016) Cardiac Gab1 deletion leads to dilated cardiomyopathy associated with mitochondrial damage and cardiomyocyte apoptosis. Cell Death Differ 23(4):695\u2013706","journal-title":"Cell Death Differ"},{"issue":"4","key":"9582_CR44","first-page":"1","volume":"109","author":"L Sun","year":"2014","unstructured":"Sun L et al (2014) Grb2-associated binder 1 is essential for cardioprotection against ischemia\/reperfusion injury. Basic Res Cardiol 109(4):1\u201315","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"9582_CR45","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4239\/wjd.v5.i4.511","volume":"5","author":"L Rui","year":"2014","unstructured":"Rui L (2014) SH2B1 regulation of energy balance, body weight, and glucose metabolism. World J Diabetes 5(4):511\u2013526","journal-title":"World J Diabetes"},{"issue":"9","key":"9582_CR46","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2337\/db08-1388","volume":"58","author":"DL Morris","year":"2009","unstructured":"Morris DL et al (2009) SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins. Diabetes 58(9):2039\u20132047","journal-title":"Diabetes"},{"issue":"17","key":"9582_CR47","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.1128\/MCB.24.17.7435-7443.2004","volume":"24","author":"C Duan","year":"2004","unstructured":"Duan C et al (2004) Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance. Mol Cell Biol 24(17):7435\u20137443","journal-title":"Mol Cell Biol"},{"issue":"2","key":"9582_CR48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2005.07.004","volume":"2","author":"D Ren","year":"2005","unstructured":"Ren D et al (2005) Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. Cell Metab 2(2):95\u2013104","journal-title":"Cell Metab"},{"issue":"2","key":"9582_CR49","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1172\/JCI29417","volume":"117","author":"D Ren","year":"2007","unstructured":"Ren D et al (2007) Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. J Clin Invest 117(2):397\u2013406","journal-title":"J Clin Invest"},{"issue":"2","key":"9582_CR50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2337\/db13-0666","volume":"63","author":"Z Chen","year":"2014","unstructured":"Chen Z et al (2014) SH2B1 in beta-cells regulates glucose metabolism by promoting beta-cell survival and islet expansion. Diabetes 63(2):585\u2013595","journal-title":"Diabetes"},{"issue":"5","key":"9582_CR51","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/me.2013-1333","volume":"28","author":"Z Chen","year":"2014","unstructured":"Chen Z et al (2014) SH2B1 in beta-cells promotes insulin expression and glucose metabolism in mice. Mol Endocrinol 28(5):696\u2013705","journal-title":"Mol Endocrinol"},{"issue":"2","key":"9582_CR52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/cvr\/cvv170","volume":"107","author":"G Wu","year":"2015","unstructured":"Wu G et al (2015) SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload. Cardiovasc Res 107(2):203\u2013215","journal-title":"Cardiovasc Res"},{"issue":"26","key":"9582_CR53","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1038\/onc.2012.435","volume":"32","author":"S Gery","year":"2013","unstructured":"Gery S, Koeffler HP (2013) Role of the adaptor protein LNK in normal and malignant hematopoiesis. Oncogene 32(26):3111\u20133118","journal-title":"Oncogene"},{"issue":"10","key":"9582_CR54","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.bcp.2011.06.023","volume":"82","author":"J Devalli\u00e8re","year":"2011","unstructured":"Devalli\u00e8re J, Charreau B (2011) The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling. Biochem Pharmacol 82(10):1391\u20131402","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"9582_CR55","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/ng.323","volume":"41","author":"DF Gudbjartsson","year":"2009","unstructured":"Gudbjartsson DF et al (2009) Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 41(3):342\u2013347","journal-title":"Nat Genet"},{"issue":"2","key":"9582_CR56","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/CIRCGENETICS.114.000527","volume":"8","author":"MJ Flister","year":"2015","unstructured":"Flister MJ et al (2015) SH2B3 is a genetic determinant of cardiac inflammation and fibrosis. Circ Cardiovasc Genet 8(2):294","journal-title":"Circ Cardiovasc Genet"},{"issue":"35","key":"9582_CR57","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1038\/sj.onc.1203080","volume":"18","author":"Y Mitsuuchi","year":"1999","unstructured":"Mitsuuchi Y et al (1999) Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine\/threonine kinase AKT2. Oncogene 18(35):4891\u20134898","journal-title":"Oncogene"},{"issue":"5","key":"9582_CR58","doi-asserted-by":"crossref","first-page":"E721","DOI":"10.1152\/ajpendo.00086.2010","volume":"299","author":"X Fang","year":"2010","unstructured":"Fang X et al (2010) An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart. Am J Physiol Endocrinol Metab 299(5):E721\u2013E729","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9582_CR59","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijcard.2016.03.240","volume":"216","author":"K Dadson","year":"2016","unstructured":"Dadson K et al (2016) Cellular, structural and functional cardiac remodelling following pressure overload and unloading. Int J Cardiol 216:32\u201342","journal-title":"Int J Cardiol"},{"issue":"8","key":"9582_CR60","doi-asserted-by":"crossref","first-page":"e103793","DOI":"10.1371\/journal.pone.0103793","volume":"9","author":"T Cao","year":"2014","unstructured":"Cao T et al (2014) AdipoR1\/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts. PLoS ONE 9(8):e103793","journal-title":"PLoS ONE"},{"issue":"7","key":"9582_CR61","doi-asserted-by":"crossref","first-page":"E795","DOI":"10.1152\/ajpendo.00257.2013","volume":"305","author":"M Park","year":"2013","unstructured":"Park M et al (2013) APPL1 transgenic mice are protected from high-fat diet-induced cardiac dysfunction. Am J Physiol Endocrinol Metab 305(7):E795\u2013E804","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"9582_CR62","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4161\/jkst.22435","volume":"1","author":"H Yasukawa","year":"2012","unstructured":"Yasukawa H et al (2012) SOCS3: a novel therapeutic target for cardioprotection. JAK-STAT 1(4):234\u2013240","journal-title":"JAK-STAT"},{"issue":"3","key":"9582_CR63","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/cvr\/cvs261","volume":"96","author":"A Cittadini","year":"2012","unstructured":"Cittadini A et al (2012) SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130\/JAK\/STAT pathway. Cardiovasc Res 96(3):381\u2013390","journal-title":"Cardiovasc Res"},{"issue":"10","key":"9582_CR64","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI13939","volume":"108","author":"H Yasukawa","year":"2001","unstructured":"Yasukawa H et al (2001) Suppressor of cytokine signaling-3 is a biomechanical stress\u2013inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. J Clin Investig 108(10):1459\u20131467","journal-title":"J Clin Investig"},{"issue":"24","key":"9582_CR65","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/CIRCULATIONAHA.111.028498","volume":"124","author":"T Yajima","year":"2011","unstructured":"Yajima T et al (2011) Absence of SOCS3 in the cardiomyocyte increases mortality in a gp130 dependent manner accompanied by contractile dysfunction and ventricular arrhythmias. Circulation 124(24):2690\u20132701","journal-title":"Circulation"},{"issue":"9","key":"9582_CR66","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jacc.2011.10.887","volume":"59","author":"T Oba","year":"2012","unstructured":"Oba T et al (2012) Cardiac-specific deletion of SOCS-3 prevents development of left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 59(9):838\u2013852","journal-title":"J Am Coll Cardiol"},{"key":"9582_CR67","first-page":"315","volume":"323","author":"KU Knowlton","year":"2008","unstructured":"Knowlton KU (2008) CVB infection and mechanisms of viral cardiomyopathy. Curr Top Microbiol Immunol 323:315\u2013335","journal-title":"Curr Top Microbiol Immunol"},{"issue":"4","key":"9582_CR68","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1172\/JCI16491","volume":"111","author":"H Yasukawa","year":"2003","unstructured":"Yasukawa H et al (2003) The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. J Clin Invest 111(4):469\u2013478","journal-title":"J Clin Invest"},{"issue":"22","key":"9582_CR69","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/CIRCULATIONAHA.106.642454","volume":"114","author":"T Yajima","year":"2006","unstructured":"Yajima T et al (2006) Innate defense mechanism against virus infection within the cardiac myocyte requiring gp130-STAT3 signaling. Circulation 114(22):2364\u20132373","journal-title":"Circulation"},{"issue":"44","key":"9582_CR70","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1038\/sj.onc.1204781","volume":"20","author":"AY Tsygankov","year":"2001","unstructured":"Tsygankov AY et al (2001) Beyond the RING: CBL proteins as multivalent adapters. Oncogene 20(44):6382\u20136402","journal-title":"Oncogene"},{"issue":"20","key":"9582_CR71","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/CIRCULATIONAHA.113.007004","volume":"129","author":"K Rafiq","year":"2014","unstructured":"Rafiq K et al (2014) c-Cbl inhibition improves cardiac function and survival in response to myocardial ischemia. Circulation 129(20):2031\u20132043","journal-title":"Circulation"},{"issue":"8","key":"9582_CR72","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1074\/jbc.M111.307009","volume":"287","author":"K Rafiq","year":"2012","unstructured":"Rafiq K et al (2012) c-Cbl ubiquitin ligase regulates focal adhesion protein turnover and myofibril degeneration induced by neutrophil protease cathepsin G. J Biol Chem 287(8):5327\u20135339","journal-title":"J Biol Chem"},{"issue":"3","key":"9582_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-014-0411-3","volume":"109","author":"A Valaperti","year":"2014","unstructured":"Valaperti A et al (2014) The adapter protein c-Cbl-associated protein (CAP) protects from acute CVB3-mediated myocarditis through stabilization of type I interferon production and reduced cytotoxicity. Basic Res Cardiol 109(3):1\u201314","journal-title":"Basic Res Cardiol"},{"issue":"Pt 4","key":"9582_CR74","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1242\/jcs.115.4.679","volume":"115","author":"JY Chung","year":"2002","unstructured":"Chung JY et al (2002) All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci 115(Pt 4):679\u2013688","journal-title":"J Cell Sci"},{"issue":"3","key":"9582_CR75","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2337\/db11-0474","volume":"61","author":"Z Chen","year":"2012","unstructured":"Chen Z et al (2012) Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses. Diabetes 61(3):566\u2013573","journal-title":"Diabetes"},{"issue":"12","key":"9582_CR76","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.molmet.2015.09.013","volume":"4","author":"Z Chen","year":"2015","unstructured":"Chen Z et al (2015) Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity. Mol Metab 4(12):951\u2013960","journal-title":"Mol Metab"},{"issue":"6","key":"9582_CR77","doi-asserted-by":"crossref","first-page":"E460","DOI":"10.1152\/ajpendo.00470.2014","volume":"308","author":"Z Chen","year":"2015","unstructured":"Chen Z et al (2015) Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity. Am J Physiol Endocrinol Metab 308(6):E460\u2013E469","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"9582_CR78","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.gene.2013.12.052","volume":"536","author":"Y Huang","year":"2014","unstructured":"Huang Y et al (2014) Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT\/GSK3\u03b2 signaling. Gene 536(2):225\u2013231","journal-title":"Gene"},{"issue":"3","key":"9582_CR79","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.000080","volume":"6","author":"VG Divakaran","year":"2013","unstructured":"Divakaran VG et al (2013) Tumor necrosis factor receptor associated factor 2 signaling provokes adverse cardiac remodeling in the adult mammalian heart. Circ Heart Fail 6(3):535\u2013543","journal-title":"Circ Heart Fail"},{"issue":"1","key":"9582_CR80","doi-asserted-by":"crossref","first-page":"e000662","DOI":"10.1161\/JAHA.113.000662","volume":"3","author":"HP Tzeng","year":"2014","unstructured":"Tzeng HP et al (2014) Dysferlin mediates the cytoprotective effects of TRAF2 following myocardial ischemia reperfusion injury. J Am Heart Assoc Cardiovasc Cerebrovasc Dis 3(1):e000662","journal-title":"J Am Heart Assoc Cardiovasc Cerebrovasc Dis"},{"issue":"2","key":"9582_CR81","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/HYPERTENSIONAHA.115.05469","volume":"66","author":"X Jiang","year":"2015","unstructured":"Jiang X et al (2015) Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy. Hypertension 66(2):356\u2013367","journal-title":"Hypertension"},{"key":"9582_CR82","doi-asserted-by":"crossref","first-page":"97","DOI":"10.12703\/P6-97","volume":"6","author":"J Deguine","year":"2014","unstructured":"Deguine J, Barton GM (2014) MyD88: a central player in innate immune signaling. F100Prime Rep 6:97","journal-title":"F100Prime Rep"},{"issue":"2","key":"9582_CR83","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cardiores.2005.05.025","volume":"68","author":"T Ha","year":"2005","unstructured":"Ha T et al (2005) Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload. Cardiovasc Res 68(2):224\u2013234","journal-title":"Cardiovasc Res"},{"issue":"3","key":"9582_CR84","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.yjmcc.2010.12.021","volume":"50","author":"G Vilahur","year":"2011","unstructured":"Vilahur G et al (2011) Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction. J Mol Cell Cardiol 50(3):522\u2013533","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"9582_CR85","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.4049\/jimmunol.180.10.6954","volume":"180","author":"A Riad","year":"2008","unstructured":"Riad A et al (2008) Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J Immunol 180(10):6954\u20136961","journal-title":"J Immunol"},{"issue":"6","key":"9582_CR86","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/01.CIR.0000112575.66565.84","volume":"109","author":"J Oyama","year":"2004","unstructured":"Oyama J et al (2004) Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109(6):784\u2013789","journal-title":"Circulation"},{"issue":"5","key":"9582_CR87","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.yjmcc.2012.01.021","volume":"52","author":"MV Singh","year":"2012","unstructured":"Singh MV et al (2012) MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction. J Mol Cell Cardiol 52(5):1135\u20131144","journal-title":"J Mol Cell Cardiol"},{"key":"9582_CR88","doi-asserted-by":"crossref","unstructured":"Ha T et al (2006) Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol 290(3):H985\u2013H994","DOI":"10.1152\/ajpheart.00720.2005"},{"issue":"9","key":"9582_CR89","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/CIRCRESAHA.109.199802","volume":"105","author":"P Blyszczuk","year":"2009","unstructured":"Blyszczuk P et al (2009) Myeloid differentiation factor-88\/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy. Circ Res 105(9):912\u2013920","journal-title":"Circ Res"},{"issue":"5","key":"9582_CR90","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00395-011-0182-z","volume":"106","author":"Y Zhu","year":"2011","unstructured":"Zhu Y et al (2011) The TIR\/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling. Basic Res Cardiol 106(5):787\u2013799","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"9582_CR91","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/HYPERTENSIONAHA.115.06011","volume":"66","author":"MV Singh","year":"2015","unstructured":"Singh MV et al (2015) Dual activation of TRIF and MyD88 adaptor proteins by angiotensin II evokes opposing effects on pressure, cardiac hypertrophy, and inflammatory gene expression. Hypertension 66(3):647\u2013656","journal-title":"Hypertension"},{"issue":"4","key":"9582_CR92","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.4049\/jimmunol.1002029","volume":"186","author":"A Riad","year":"2011","unstructured":"Riad A et al (2011) TRIF is a critical survival factor in viral cardiomyopathy. J Immunol 186(4):2561\u20132570","journal-title":"J Immunol"},{"issue":"1","key":"9582_CR93","doi-asserted-by":"crossref","first-page":"e000683","DOI":"10.1161\/JAHA.113.000683","volume":"3","author":"C Chen","year":"2014","unstructured":"Chen C et al (2014) Role of extracellular RNA and TLR3-trif signaling in myocardial ischemia-reperfusion injury. J Am Heart Assoc Cardiovasc Cerebrovascu Dis 3(1):e000683","journal-title":"J Am Heart Assoc Cardiovasc Cerebrovascu Dis"},{"issue":"7","key":"9582_CR94","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116(7):1793\u20131801","journal-title":"J Clin Invest"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-016-9582-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-016-9582-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-016-9582-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T07:18:09Z","timestamp":1657264689000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-016-9582-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,13]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["9582"],"URL":"https:\/\/doi.org\/10.1007\/s10741-016-9582-3","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"type":"print","value":"1382-4147"},{"type":"electronic","value":"1573-7322"}],"subject":[],"published":{"date-parts":[[2016,9,13]]}}}